{"id":463575,"title":"Draft guidance on proposed new Clinical Trials Regulations (GUI-0100) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-05","captureTimestamp":"2026-01-05T01:31:06.812000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-modernizing-framework-clinical-trials/draft-guidance-proposed-new-regulations-gui-0100.html?wbdisable=false","snippet":"Draft guidance on proposed new Clinical Trials Regulations (GUI-0100) This draft guidance is for consultation only. For current guidance please see the existing guidance document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human…","rawSnapshotUrl":"/api/snapshots/raw/463575","browseUrl":"https://replay.healtharchive.ca/job-6/20260105013106/https://www.canada.ca/en/health-canada/programs/consultation-modernizing-framework-clinical-trials/draft-guidance-proposed-new-regulations-gui-0100.html?wbdisable=false#ha_snapshot=463575","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}